Stage I Breast Cancer AJCC v7

Oncology·MeSH: Triple Negative Breast Neoplasms

Prevalence

287.0 / 100K

Incidence

128.0 / 100K/yr

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Stage I Breast Cancer AJCC v7?

There are 2 clinical trials targeting Stage I Breast Cancer AJCC v7 tracked by BioSniper.

What is the prevalence of Stage I Breast Cancer AJCC v7?

The estimated prevalence of Stage I Breast Cancer AJCC v7 is approximately 287.0 per 100,000 population.

Deep-dive into Stage I Breast Cancer AJCC v7

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Stage I Breast Cancer AJCC v7 — Drugs in Development & Clinical Trials | BioSniper